FOS and hypopharyngeal carcinoma: The results showed that the expression levels of FOS (an MAPK pathway-related gene), SERPINE1 (a TGF-β pathway-related gene), and BCL2L11 (a FoxO pathway-related gene) were significantly higher in hypopharyngeal carcinoma tissues than in adjacent non-tumor tissues (Figure 4H).